Section of Oral and Maxillofacial Pathology, Department of Oral Diagnostic Sciences, Faculty of Dentistry, Prince of Songkla University, Hatyai, Songkhla, Thailand.
Section of Oral and Maxillofacial Radiology, Department of Oral Diagnostic Sciences, Faculty of Dentistry, Prince of Songkla University, Hatyai, Songkhla, Thailand.
Head Neck Pathol. 2024 Aug 23;18(1):82. doi: 10.1007/s12105-024-01686-7.
This scoping review aimed to identify factors associated with the recurrence of ameloblastoma.
Systematic searches were conducted in PubMed, Scopus, and EMBASE, based on the board research question: "What factors are related to the recurrence of ameloblastoma?". English-language observational studies addressing the risk and preventive factors associated with recurrent ameloblastoma were included and data were extracted.
Eighty-three retrospective observational studies met the inclusion criteria. The identified prognostic factors for recurrence included: (1) Tumor size/diameter/volume, (2) cortical bone perforation/ soft tissue invasion, (3) multilocular radiolucency, (4) impacted tooth-involving lesions, (5) root resorption, (6) WHO classification - conventional (solid/multicystic) ameloblastoma, (7) histological subtype - mural invasion of unicystic ameloblastoma, (8) conservative treatment modalities - simple enucleation, curettage, and marsupialization, and (9) non-extraction/preservation of involved teeth. No strong evidence linked immunohistochemical expression to recurrence. Interestingly, BRAF p.V600E remained controversial in terms of recurrence, despite being a frequent finding in ameloblastoma.
Certain clinical characteristics, radiographic findings, histological subtypes, and treatment choices of ameloblastoma can help identify patients at high risk of recurrence. Further prospective studies to evaluate the prognostic factor model and research on immunohistochemistry are required.
本范围综述旨在确定与成釉细胞瘤复发相关的因素。
根据委员会提出的研究问题,在 PubMed、Scopus 和 EMBASE 中进行系统检索:“哪些因素与成釉细胞瘤的复发有关?”。纳入了涉及与复发性成釉细胞瘤相关的风险和预防因素的英文观察性研究,并提取了数据。
83 项回顾性观察性研究符合纳入标准。确定的复发预测因素包括:(1)肿瘤大小/直径/体积,(2) 皮质骨穿孔/软组织侵犯,(3)多房性透亮区,(4)累及牙齿的埋伏性病变,(5)牙根吸收,(6)WHO 分类-常规(实性/多囊性)成釉细胞瘤,(7)组织学亚型-单囊型成釉细胞瘤的壁内侵犯,(8)保守治疗方法-单纯剜除、刮除和袋形术,以及(9)未拔牙/保留受累牙齿。没有强有力的证据表明免疫组织化学表达与复发有关。有趣的是,尽管 BRAF p.V600E 在成釉细胞瘤中频繁发现,但它与复发的相关性仍存在争议。
成釉细胞瘤的某些临床特征、影像学表现、组织学亚型和治疗选择有助于识别复发风险较高的患者。需要进一步开展前瞻性研究来评估预后因素模型,并研究免疫组织化学。